SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
149 hedge funds and large institutions have $291M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
51% less call options, than puts
Call options by funds: $4.07M | Put options by funds: $8.28M
Holders
149
Holding in Top 10
–
Calls
$4.07M
Puts
$8.28M
Top Buyers
| 1 | +$26.3M | |
| 2 | +$16.2M | |
| 3 | +$15.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.49M |
| 5 |
BlackRock
New York
|
+$3.93M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$39.5M | |
| 3 | -$13.1M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.49M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.83M |